MORTIMER IAN (PRESIDENT & CFO) sold 44.4% of their position (25K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $1.00M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/1/2025ACC: 0001193125-25-227202
Officer· PRESIDENT & CFO
Since Sep 2019
-25K
Net shares
Net seller
$1.00M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+25K
Price / share
$7.69
Trade value
$192.25K
% of position
79.9%
10/1/2025
31.30K→56.30K
Common Shares
Direct
Shares
−25K
Price / share
$40.16
Trade value
$1M
% of position
44.4%
10/1/2025
56.30K→31.30K
Total
Net shares
+0.00
Net value
-$811.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 10/1/2025 | M · Option Exercise | +25K | $7.69 | $192.25K | 79.9% | 31.30K | 56.30K |
| Common Shares Direct | 10/1/2025 | S · Sale | −25K | $40.16 | $1M | 44.4% | 56.30K | 31.30K |
| Total | +0.00 | -$811.75K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
25K shares
Shares
−25K
Strike price
7.69
Held after
0.00
Exercisable
—
10/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares25K shares | 10/1/2025 | M · Option Exercise | −25K | 7.69 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned14.30K
Total
14.30K indirect14.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 14.30K | Indirect |
| Total | 14.30K | 14.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported